Cardiovascular Systems, Inc. (NASDAQ:CSII) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Thursday.

Other equities analysts have also recently issued reports about the stock. Needham & Company LLC reiterated a “buy” rating and issued a $32.00 target price on shares of Cardiovascular Systems in a research note on Tuesday, April 18th. TheStreet upgraded shares of Cardiovascular Systems from a “d” rating to a “c-” rating in a research note on Thursday, May 4th. Zacks Investment Research cut shares of Cardiovascular Systems from a “buy” rating to a “hold” rating in a research note on Thursday, March 16th. Finally, Bank of America Corporation cut shares of Cardiovascular Systems from a “neutral” rating to an “underperform” rating in a research note on Wednesday, June 21st. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Buy” and an average price target of $33.83.

Shares of Cardiovascular Systems (NASDAQ CSII) traded up 2.69% during mid-day trading on Thursday, hitting $32.44. 222,161 shares of the stock were exchanged. The company’s market cap is $1.06 billion. Cardiovascular Systems has a 52-week low of $18.67 and a 52-week high of $33.11. The stock’s 50-day moving average price is $31.22 and its 200-day moving average price is $28.18.

Cardiovascular Systems (NASDAQ:CSII) last announced its quarterly earnings data on Wednesday, May 3rd. The medical device company reported ($0.05) EPS for the quarter, meeting the consensus estimate of ($0.05). Cardiovascular Systems had a negative net margin of 3.72% and a negative return on equity of 4.36%. The business had revenue of $52.10 million during the quarter, compared to analysts’ expectations of $51.13 million. During the same period in the previous year, the business posted ($0.31) EPS. The business’s quarterly revenue was up 17.1% compared to the same quarter last year. Equities research analysts anticipate that Cardiovascular Systems will post ($0.13) earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This story was first posted by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2017/07/16/bidaskclub-lowers-cardiovascular-systems-inc-csii-to-hold.html.

Several institutional investors have recently bought and sold shares of the stock. California Public Employees Retirement System boosted its position in Cardiovascular Systems by 0.6% in the first quarter. California Public Employees Retirement System now owns 31,900 shares of the medical device company’s stock valued at $902,000 after buying an additional 200 shares in the last quarter. Chicago Equity Partners LLC boosted its position in Cardiovascular Systems by 1.0% in the first quarter. Chicago Equity Partners LLC now owns 30,890 shares of the medical device company’s stock valued at $873,000 after buying an additional 300 shares in the last quarter. US Bancorp DE boosted its position in Cardiovascular Systems by 14.3% in the first quarter. US Bancorp DE now owns 8,708 shares of the medical device company’s stock valued at $246,000 after buying an additional 1,091 shares in the last quarter. Winslow Evans & Crocker Inc. boosted its position in Cardiovascular Systems by 21.3% in the second quarter. Winslow Evans & Crocker Inc. now owns 6,550 shares of the medical device company’s stock valued at $210,000 after buying an additional 1,150 shares in the last quarter. Finally, American International Group Inc. boosted its position in Cardiovascular Systems by 7.1% in the first quarter. American International Group Inc. now owns 19,619 shares of the medical device company’s stock valued at $555,000 after buying an additional 1,297 shares in the last quarter. Hedge funds and other institutional investors own 75.85% of the company’s stock.

Cardiovascular Systems Company Profile

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

Analyst Recommendations for Cardiovascular Systems (NASDAQ:CSII)

Receive News & Ratings for Cardiovascular Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.